HBeAg-话题@MedSci

#HBeAg#

30篇内容 | 1187人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200230, encodeId=3a432200230f9, content=<a href='/topic/show?id=3ed881343fa' target=_blank style='color:#2F92EE;'>#肝纤维化#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=【期刊导读】吴超/黄睿/朱传武教授：HBV DNA检测不到且ALT正常的初治HBeAg阴性慢性HBV感染者的临床结局探索, objectType=article, longId=822338, objectId=85db82233857, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/nurse-prepares-salbutamol-aerosols-in-a-hospital-JC8LB7N.jpg, objectUrl=/article/show_article.do?id=85db82233857, replyNumber=0, likeNumber=3, createdTime=2024-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=85db82233857, moduleTitle=【期刊导读】吴超/黄睿/朱传武教授：HBV DNA检测不到且ALT正常的初治HBeAg阴性慢性HBV感染者的临床结局探索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85db82233857)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200004, encodeId=bb60220000466, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2023】HBeAg阴性初治慢乙肝患者HBsAg仍阳性时停药，HBV DNA复阳后再治疗获HBsAg血清学转换, objectType=article, longId=822188, objectId=22548221885b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-student-working-with-pad-on-the-PLC9ULE.jpg, objectUrl=/article/show_article.do?id=22548221885b, replyNumber=0, likeNumber=4, createdTime=2024-04-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=22548221885b, moduleTitle=【愈见乙肝2023】HBeAg阴性初治慢乙肝患者HBsAg仍阳性时停药，HBV DNA复阳后再治疗获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22548221885b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198998, encodeId=8f6121989989e, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】HBeAg阳性慢乙肝患者核苷停药后病毒学复发率达68%，停药时HBsAg水平与病毒复发及HBsAg清除相关, objectType=article, longId=821047, objectId=767282104e8a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=767282104e8a, replyNumber=0, likeNumber=9, createdTime=2024-04-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=767282104e8a, moduleTitle=【期刊导读】HBeAg阳性慢乙肝患者核苷停药后病毒学复发率达68%，停药时HBsAg水平与病毒复发及HBsAg清除相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=767282104e8a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1368971, encodeId=513313689e1eb, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, objectType=article, longId=736354, objectId=8d4ce36354d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4ce36354d3, replyNumber=0, likeNumber=36, createdTime=2022-08-21, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4ce36354d3, moduleTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4ce36354d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368970, encodeId=d4f913689e064, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Front Immunol ：干扰素α-2a治疗HBeAg阳性慢性乙型肝炎过程中细胞因子和病毒学标志物的动态变化, objectType=article, longId=736351, objectId=9244e3635169, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9244e3635169, replyNumber=0, likeNumber=38, createdTime=2022-08-21, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9244e3635169, moduleTitle=Front Immunol ：干扰素α-2a治疗HBeAg阳性慢性乙型肝炎过程中细胞因子和病毒学标志物的动态变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9244e3635169)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368969, encodeId=08b0136896959, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响, objectType=article, longId=728103, objectId=4b08e2810361, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b08e2810361, replyNumber=0, likeNumber=44, createdTime=2022-05-30, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b08e2810361, moduleTitle=CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b08e2810361)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368968, encodeId=1ae4136896864, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Front Immunol：HBeAg阳性慢性HBV感染孕妇产后肝炎暴发的临床特征及T细胞免疫特征, objectType=article, longId=727863, objectId=413de278637e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=413de278637e, replyNumber=0, likeNumber=37, createdTime=2022-05-27, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=413de278637e, moduleTitle=Front Immunol：HBeAg阳性慢性HBV感染孕妇产后肝炎暴发的临床特征及T细胞免疫特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=413de278637e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368967, encodeId=b4d3136896ed6, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度, objectType=article, longId=726137, objectId=82c5e2613787, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82c5e2613787, replyNumber=0, likeNumber=32, createdTime=2022-05-06, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82c5e2613787, moduleTitle=J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82c5e2613787)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368966, encodeId=55d91368966d9, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响, objectType=article, longId=217119, objectId=e86e21e119cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e86e21e119cf, replyNumber=0, likeNumber=20, createdTime=2021-09-16, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e86e21e119cf, moduleTitle=Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e86e21e119cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368965, encodeId=a1e21368965e5, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, objectType=article, longId=216950, objectId=dc6821695029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc6821695029, replyNumber=0, likeNumber=48, createdTime=2021-09-12, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc6821695029, moduleTitle=Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc6821695029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368964, encodeId=77d4136896452, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatology：乙肝纳米疫苗εPA-44可明显提高CHB患者的HBeAg血清学转换率, objectType=article, longId=215974, objectId=5cf22159e493, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5cf22159e493, replyNumber=0, likeNumber=52, createdTime=2021-08-20, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5cf22159e493, moduleTitle=Hepatology：乙肝纳米疫苗εPA-44可明显提高CHB患者的HBeAg血清学转换率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5cf22159e493)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368963, encodeId=cc2f136896334, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=拨丝抽茧-如何看待HBeAg与HBeAb“共生”, objectType=article, longId=208892, objectId=098720889280, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=098720889280, replyNumber=0, likeNumber=42, createdTime=2021-03-25, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=098720889280, moduleTitle=拨丝抽茧-如何看待HBeAg与HBeAb“共生”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=098720889280)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368962, encodeId=bb0a136896220, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, objectType=article, longId=206053, objectId=87a720605372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87a720605372, replyNumber=0, likeNumber=51, createdTime=2021-01-24, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87a720605372, moduleTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87a720605372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368961, encodeId=57721368961e0, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Clin Virol：HBeAg 的血清学检测性能特点的评估, objectType=article, longId=160961, objectId=a0fc160961cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0fc160961cf, replyNumber=0, likeNumber=31, createdTime=2019-02-25, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0fc160961cf, moduleTitle=J Clin Virol：HBeAg 的血清学检测性能特点的评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0fc160961cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368960, encodeId=2eca1368960df, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Hepatol：以HBeAg和ALT为基础的简单评分，在选择需要治疗的HBV患者上，具有较高的诊断准确性, objectType=article, longId=149270, objectId=b2a21492e079, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2a21492e079, replyNumber=0, likeNumber=29, createdTime=2018-09-22, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2a21492e079, moduleTitle=J Hepatol：以HBeAg和ALT为基础的简单评分，在选择需要治疗的HBV患者上，具有较高的诊断准确性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2a21492e079)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368959, encodeId=1cb5136895999, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, objectType=article, longId=140814, objectId=73b414081494, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b414081494, replyNumber=0, likeNumber=44, createdTime=2018-06-16, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b414081494, moduleTitle=J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b414081494)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368958, encodeId=baad136895821, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, objectType=article, longId=135062, objectId=0b8e13506250, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b8e13506250, replyNumber=0, likeNumber=44, createdTime=2018-04-13, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b8e13506250, moduleTitle=HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b8e13506250)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368957, encodeId=5fc1136895e2e, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, objectType=article, longId=132313, objectId=bb6013231302, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb6013231302, replyNumber=0, likeNumber=27, createdTime=2018-03-15, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb6013231302, moduleTitle=Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb6013231302)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368956, encodeId=5f1e13689560a, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, objectType=article, longId=132044, objectId=d3a81320444c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a81320444c, replyNumber=0, likeNumber=43, createdTime=2018-03-12, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a81320444c, moduleTitle=J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3a81320444c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1368955, encodeId=33151368955bb, content=<a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a>, objectTitle=Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素, objectType=article, longId=130742, objectId=f1af130e425f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1af130e425f, replyNumber=0, likeNumber=44, createdTime=2018-02-28, rootId=0, userName=xiaoshitou, userId=0357291, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1af130e425f, moduleTitle=Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1af130e425f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBeAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝纤维化# #HBV# #HBeAg#

【期刊导读】吴超/黄睿/朱传武教授：HBV DNA检测不到且ALT正常的初治HBeAg阴性慢性HBV感染者的临床结局探索

2024-04-24发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBeAg# #慢乙肝#

【愈见乙肝2023】HBeAg阴性初治慢乙肝患者HBsAg仍阳性时停药，HBV DNA复阳后再治疗获HBsAg血清学转换

2024-04-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBeAg# #慢乙肝#

【期刊导读】HBeAg阳性慢乙肝患者核苷停药后病毒学复发率达68%，停药时HBsAg水平与病毒复发及HBsAg清除相关

2024-04-17发表于陕西省

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关

2022-08-21

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Front Immunol ：干扰素α-2a治疗HBeAg阳性慢性乙型肝炎过程中细胞因子和病毒学标志物的动态变化

2022-08-21

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

CGH: HBeAg阳性不会对慢性乙型肝炎患者口服抗病毒治疗期间肝细胞癌风险产生影响

2022-05-30

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Front Immunol：HBeAg阳性慢性HBV感染孕妇产后肝炎暴发的临床特征及T细胞免疫特征

2022-05-27

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Gastroenterology：血清可溶性程序性死亡1(sPD-1)可预测慢性乙型肝炎的自发HBeAg 血清学清除程度

2022-05-06

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Clin Gastroenterology H: HBeAg 对慢性乙型肝炎患者口服抗病毒药物治疗期间肝细胞癌风险的影响

2021-09-16

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Clin Gastroenterol Hepatol：抗病毒治疗时的HBeAg状态对慢性乙肝患者患肝癌风险的影响

2021-09-12

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatology：乙肝纳米疫苗εPA-44可明显提高CHB患者的HBeAg血清学转换率

2021-08-20

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

拨丝抽茧-如何看待HBeAg与HBeAb“共生”

2021-03-25

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况

2021-01-24

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Clin Virol：HBeAg 的血清学检测性能特点的评估

2019-02-25

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Hepatol：以HBeAg和ALT为基础的简单评分，在选择需要治疗的HBV患者上，具有较高的诊断准确性

2018-09-22

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Viral Hepat：慢乙肝患者HBeAg血清学转换后肝癌风险显著降低

2018-06-16

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

HBeAg阴性慢乙肝抗病毒治疗及HBsAg清除相关优化治疗策略

2018-04-13

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Aliment Pharmacol Ther：停药or继续治疗？HBeAg阳性患者NA治疗获得HBeAg血清学转换后……

2018-03-15

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

J Med Virol：在HBeAg/anti-HBe血清学转换过程中，HBV基因D型儿童HBV Pre-Core的选择性突变，导致成年后HBeAg阴性慢性乙型

2018-03-12

xiaoshitou (审核中...)

前往app查看评论内容

#HBeAg#

Hepatol Res：在HBeAg阳性母亲中，病毒载量是母婴传播风险的一个重要危险因素

2018-02-28

科室
- - 订阅+
  - 更多科室
工具
服务